why choose us

First received: July 17, 2025

Clinical Trial: Reformulated PG324 Ophthalmic Solution for Intraocular Pressure Reduction

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Ocular Hypertension

Study Type: INTERVENTIONAL


Official Title: A Phase III, Prospective, Double-Masked, Randomized, Multi-Center, Active-Controlled, Parallel Group Comparison Study Assessing the Ocular Hypotensive Efficacy of Reformulated PG324 Ophthalmic Solutio

Brief Summary: This study is designed to see how safe and effective a new eye drop, called Reformulated PG324, is for lowering eye pressure in people with open-angle glaucoma (OAG) or ocular hypertension (OHT).

Read more